Papers In Press, published online ahead of print March 24, 2008
J. Biol. Chem, 10.1074/jbc.C800036200
Submitted on February 20, 2008
Revised on March 17, 2008
Accepted on March 24, 2008
Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi
Susanne Radke, Harish Chander, Patrick Schäfer, Gregor Meiss, Rejko Krüger, Jörg B. Schulz, and Doris Germain
Medicine, Hematology/Oncology, Mount Sinai School of medicine, New York
Corresponding Author: doris.germain{at}mssm.edu
We report here that blocking the activity of the 26S proteasome results in drastic changes in the morphology of the mitochondria and accumulation of inter-membrane space (IMS) proteins. Using endonuclease G (endoG) as a model IMS protein, we found that accumulation of wild-type but to a greater extent mutant endoG leads to changes in the morphology of the mitochondria similar to those observed following proteasomal inhibition. Further, we show that wild-type but to a greater extent mutant endoG is a substrate for ubiquitination suggesting the presence of a protein quality control (PQC). Conversely, we also report that wild-type but not mutant endoG is a substrate for the mitochondrial protease Omi but only upon inhibition of the proteasome. These findings suggest that while elimination of mutant IMS proteins is strictly dependent on ubiquitination, elimination of excess or spontaneously misfolded wild-type IMS proteins is monitored by ubiquitination and as a second checkpoint by Omi cleavage when the proteasome function is deficient. One implication of our finding is that in the context of attenuated proteasomal function, accumulation of IMS proteins would contribute to the collapse of the mitochondrial network such as that observed in neurodegenerative diseases. Another implication is that such collapse could be accelerated either by mutations in IMS proteins or in Omi itself. This possibility is supported by the fact that Omi is mutated in Parkinsons disease